Health Reading List | January 29, 2016 | Startup Highlight: HemoShear Therapeutics
HemoShear is a biotech company that has created incredible human disease models that could drastically reduce the cost to develop drugs. Standard animal models just don't work very well, which is a large part of the cost associated with drug development. The closer we can get to mimicking human physiology while developing drugs, the more we can cut in terms of cost. If you'd like to learn more HemoShear was also featured on this week's Biotech Nation.
As always, if you come across news, announcements, videos, or podcasts that you think everyone else would benefit from, e-mail me at scott.munro@startupdigestmail.com or tweet @R_Scott_Munro. | Set Your Startup Apart with Startup Next, a Techstars Program Get 1:1 mentorship and hone in on your pitch, product-market fit, funding and more. Startup Next is a free 5-week program, with plenty of post program value adds that will put you one step ahead of other startups. Access thousands of mentors, founders, and investors all while preparing for seed funding or applying to an accelerator. Subscribe to find out when Startup Next is accepting applications! | | What do you do after you're done being the VP of the free world? You lead a task force to end cancer, of course. The White House focus on precision medicine and cancer research isn't new, and frankly there is still a lot of question marks around whether or not precision medicine truly lowers cost burdens for the health care system. But you can read the VPOTUS' thoughts on the task force, here. | | People who have subscribed to this digest for some time will know I am not a fan of the wearable hype; however, I AM a huge fan of biosensors that do more than simply track our steps, enter "sweat" sensors. A group from Berkeley is convinced that they can track all sorts of markers through sweat from electrolytes, to chemicals, proteins, and diseases. Just another step towards more meaningful biosensors. | | Using light to stimulate brain function could be the future... "This nascent technology is called optogenetics, and scientists are eager to explore it. The idea: Light-sensitive proteins are inserted into cells using gene therapy. Then neurons can be delicately activated or quieted using light patterns conveyed through implanted fiber optics. These patterns more accurately mimic the electrochemical pulses of the brain's language." | | "For the first time, scientists have pinned down a molecular process in the brain that helps to trigger schizophrenia. The researchers involved in the landmark study, which was published Wednesday in the journal Nature, say the discovery of this new genetic pathway probably reveals what goes wrong neurologically in a young person diagnosed with the devastating disorder." | | A quick look at some of the public private partnerships that are making headway in healthcare innovation across the country. | | A great history of Phil Kennedy's work connecting human's to computers to help with disabilities, and his own experience "hacking" his brain. You can file this under "long reads." | | | You are receiving this email because you believe that the best startup articles and videos are made by active members of the startup community. Startup Digest, © 2009-2016 by Techstars Central LLC. All rights reserved. Startup Digest is a registered trademark of Techstars Central, LLC. Privacy Policy. | | |
No comments:
Post a Comment